Aligos Therapeutics (ALGS) Presents Positive Clinical Data a

Aligos Therapeutics (ALGS) Presents Positive Clinical Data at Hep-DART 2023 from Phase 1 Studies in HBV (ALG-000184) and NASH (ALG-055009)

Aligos Therapeutics (ALGS) Presents Positive Clinical Data at Hep-DART 2023 from Phase 1 Studies in HBV (ALG-000184) and NASH (ALG-055009)

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Mexico , Cabo San Lucas , Baja California Sur , Lawrence Blatt , Nasdaq , Aligos Therapeutics Inc , Aligos Therapeutics , Long Term Dosing , Unprecedented Multi Log Reductions , Multiple Ascending Oral Doses , Thyroid Hormone Receptor Beta Agonist , Hyperlipidaemic Subjects , Food Effect , Solid Formulation ,